Home › Non-Small Cell Lung Cancer › Texas › Arlington
Non-Small Cell Lung Cancer clinical trials in Arlington, TX
4 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Texas Oncology - DFW, Arlington
- The Center for Cancer and Blood Disorders, Arlington
- Texas Oncology - DFW, Arlington
- and 1 more
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Texas Oncology - DFW, Arlington
- Texas Oncology - DFW, Arlington
- Texas Oncology - DFW, Bedford · 8 mi away
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecruitingPhase 2/3
- Local Institution - 007-879-A, Arlington
- Local Institution - 007-879-B, Arlington
- Local Institution - 007-879-C, Bedford · 8 mi away
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- Texas Oncology, Bedford · 8 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN96 studies
- Boston, MA89 studies
- Los Angeles, CA87 studies
- St. Louis, MO71 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH55 studies
- Washington, DC54 studies
Other studies in Arlington
- Steatotic Liver Disease6 studies
- Crohn's Disease5 studies
- Chronic Kidney Disease4 studies
- Atopic Dermatitis (Eczema)4 studies
- Lupus4 studies
- Psoriatic Arthritis4 studies
- Sjogren's Syndrome4 studies
- Ulcerative Colitis4 studies
- Rheumatoid Arthritis4 studies
- Colorectal Cancer3 studies
- Cardiovascular Disease3 studies
- Prostate Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.